SOURCE: MedPageTODAY
DATE: August 14, 2008
EXCERPT: " Serious injection-site reactions, including abscesses that required surgical treatment up to debridement, have been reported in patients given naltrexone (Vivitrol) injections for alcoholism prevention. ... The FDA said data indicated that there is a variable depth of subcutaneous tissue dependent on the gender and weight of the patient. "Women may be physiologically at higher risk for injection-site reactions due to typically higher gluteal fat thickness," the FDA said. ..." more
RELATED LINK:
FDA ALERT [08/12/2008] Information for Healthcare Professionals: Naltrexone Injection Site Reactions
[naltrexone for extended-release injectable suspension (marketed as Vivitrol)] http://www.fda.gov/cder/drug/InfoSheets/HCP/naltrexoneHCP.htm
Comments